WealthPlan Investment Management LLC Acquires 217 Shares of UnitedHealth Group Incorporated $UNH

WealthPlan Investment Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,147 shares of the healthcare conglomerate’s stock after acquiring an additional 217 shares during the period. WealthPlan Investment Management LLC’s holdings in UnitedHealth Group were worth $358,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Alta Capital Management LLC boosted its position in UnitedHealth Group by 6.1% in the 2nd quarter. Alta Capital Management LLC now owns 121,624 shares of the healthcare conglomerate’s stock valued at $37,943,000 after buying an additional 7,006 shares during the last quarter. Bridges Investment Management Inc. boosted its position in UnitedHealth Group by 7.1% in the 2nd quarter. Bridges Investment Management Inc. now owns 303,336 shares of the healthcare conglomerate’s stock valued at $94,632,000 after buying an additional 20,163 shares during the last quarter. Patten & Patten Inc. TN boosted its position in UnitedHealth Group by 26.6% in the 2nd quarter. Patten & Patten Inc. TN now owns 51,901 shares of the healthcare conglomerate’s stock valued at $16,191,000 after buying an additional 10,893 shares during the last quarter. Callahan Advisors LLC boosted its position in UnitedHealth Group by 2.9% in the 2nd quarter. Callahan Advisors LLC now owns 48,213 shares of the healthcare conglomerate’s stock valued at $15,041,000 after buying an additional 1,355 shares during the last quarter. Finally, Smart Portfolios LLC boosted its position in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Smart Portfolios LLC now owns 1,922 shares of the healthcare conglomerate’s stock worth $600,000 after purchasing an additional 65 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Jefferies Financial Group raised their price target on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday. KeyCorp raised their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Piper Sandler reduced their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Finally, Bank of America raised their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $385.13.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $356.53 on Friday. The stock’s fifty day simple moving average is $329.38 and its 200 day simple moving average is $344.86. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a market capitalization of $322.90 billion, a PE ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business earned $6.80 EPS. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.